printable version:

Contacts:

Home:

Capacity Strengthening:

Scientific Programme:

Consortium Protocols:

Clinical Trials/Workshop Programmes:

Meeting Archive:

InterTB Home

International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis (INTERTB)

Meeting Archive

This page contains links to current and past meeting information

  • Meeting for for World TB Day, 24th March 2007 at St George's University of London (meeting home page, World TB Day meeting agenda). The objectives of the meeting are :
    • To review the current UK effort to reduce treatment duration with currently used drugs
    • To review the current status of new drug development
    • To discuss how both these efforts can best be taken forward internationally.
  • Workshop to be held in Durban, South Africa on the 5th, 6th and 7th March, 2007
  • The workshop took place at the Unit for Clinical and Biomedical TB Research of the South African Medical Research Council, . Participants came from South Africa, Mozambique, Zambia, Zimbabwe, Nigeria, Republic of Benin and Republic of Guinea.
 durban

  • The workshop agenda addressed the following topics:
    1. Framing the research question and preparing the protocol
    2. Statistical matters such sample size, significance, and power
    3. Study procedures such as randomisation, enrolment, treatment and follow-up.
    4. Data management and reporting the results
    5. Laboratory procedures relevant to the TB programme's studies
    6. Human subjects protection as stipulated by the ICH GCP Guidelines
    7. Intellectual property rights.
    • Meeting to be held in Lima, 20-23 February 2006
      • Meeting: CONFERENCE: NETWORK FOR TUBERCULOSIS RESEARCH IN LATIN AMERICA. Lima, 20-23 February 2006. Enquiries please contact Mary Alexander
    • Meeting to be held in Johannesburg in January, 2006.
      • preparatory meeting of the participating centres.  The agenda is available here. INTERTB Clinical Trials Programme plans to carry out a controlled clinical trial to evaluate high dose rifapentine and a fluoroquinolone in the treatment of pulmonary tuberculosis (RIFAQUIN TRIAL).